Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors

被引:42
作者
Scholz, Matthias [1 ]
Blobaum, Anna L. [2 ,3 ,4 ,5 ]
Marnett, Lawrence J. [2 ,3 ,4 ,5 ]
Hey-Hawkins, Evamarie [1 ]
机构
[1] Univ Leipzig, Inst Anorgan Chem, D-04103 Leipzig, Germany
[2] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Dept Biochem,Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Chem, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Dept Pharmacol, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Carborane; Carbaborane; Cyclooxygenase; Indomethacin; Nonsteroidal anti-inflammatory drugs; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DICARBA-CLOSO-DODECABORANES; HYDROPHOBIC PHARMACOPHORE; ICOSAHEDRAL CARBORANES; MEDICINAL CHEMISTRY; POTENT; AGONISTS; BEARING; DESIGN; ANTAGONISTS;
D O I
10.1016/j.bmc.2011.03.054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs) exert their pharmacological activities by inhibiting cyclooxygenase (COX)-1 and COX-2. Previous studies have shown that esters and amides of nonselective inhibitors such as indomethacin are selective against COX-2, which is the therapeutically relevant isoform. Structure-activity analysis indicates that substituted phenyl rings are tolerated as ester components. In the present study, the introduction of inorganic ortho-and meta-carbaborane moieties was explored with the aim to create COX-2 inhibitors and more importantly to investigate the validity of using these boron clusters as drug entities. Interestingly, only the ortho-carbaborane ester was active whereas the meta isomer was not. A similar lack of inhibitory potency was observed when an adamantyl substituent or alkylene spacers at the carbaborane were introduced in the ester functionality. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3242 / 3248
页数:7
相关论文
共 41 条
[1]   COMPLETION AND REFINEMENT OF CRYSTAL-STRUCTURES WITH SIR92 [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, C ;
GUAGLIARDI, A .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 (pt 3) :343-350
[2]   The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy [J].
Armstrong, Andrea F. ;
Valliant, John F. .
DALTON TRANSACTIONS, 2007, (38) :4240-4251
[3]   Adenosine and 2′-Deoxyadenosine Modified with Boron Cluster Pharmacophores as New Classes of Human Blood Platelet Function Modulators [J].
Bednarska, Katarzyna ;
Olejniczak, Agnieszka B. ;
Wojtczak, Blazej A. ;
Sulowska, Zofia ;
Lesnikowski, Zbigniew J. .
CHEMMEDCHEM, 2010, 5 (05) :749-756
[4]   Preparation and Evaluation of Carborane Analogues of Tamoxifen [J].
Beer, Michael L. ;
Lemon, Jennifer ;
Valliant, John F. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) :8012-8020
[5]  
Bregadze V. I., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P75, DOI 10.2174/187152006776119180
[6]   DICARBA-CLOSO-DODECABORANES C2B10H12 AND THEIR DERIVATIVES [J].
BREGADZE, VI .
CHEMICAL REVIEWS, 1992, 92 (02) :209-223
[7]   Synthesis and structural characterization of hydroxyethyl- and alkoxyethyl-o-carboranes and their alkali and rare earth metal complexes [J].
Cheung, MS ;
Chan, HS ;
Xie, ZW .
ORGANOMETALLICS, 2004, 23 (03) :517-526
[8]  
DIAGOMESEGUER J, 1980, SYNTHESIS-STUTTGART, P547
[9]   SYNTHESIS OF NEW BUILDING-BLOCKS FOR BORON-RICH OLIGOMERS IN BORON NEUTRON-CAPTURE THERAPY (BNCT) .1. [J].
DRECHSEL, K ;
LEE, CS ;
LEUNG, EW ;
KANE, RR ;
HAWTHORNE, MF .
TETRAHEDRON LETTERS, 1994, 35 (34) :6217-6220
[10]   Protein kinase C modulators bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore [J].
Endo, Y ;
Yoshimi, T ;
Kimura, K ;
Itai, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) :2561-2564